X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dr. Reddys with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ABBOTT INDIA - Comparison Results

DR. REDDYS LAB    Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB ABBOTT INDIA DR. REDDYS LAB/
ABBOTT INDIA
 
P/E (TTM) x 22.4 40.2 55.8% View Chart
P/BV x 3.4 10.7 32.0% View Chart
Dividend Yield % 0.8 0.6 119.5%  

Financials

 DR. REDDYS LAB   ABBOTT INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-18
ABBOTT INDIA
Mar-18
DR. REDDYS LAB/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,7886,110 45.6%   
Low Rs1,9023,996 47.6%   
Sales per share (Unadj.) Rs860.81,552.2 55.5%  
Earnings per share (Unadj.) Rs57.1188.8 30.2%  
Cash flow per share (Unadj.) Rs122.0196.4 62.1%  
Dividends per share (Unadj.) Rs20.0055.00 36.4%  
Dividend yield (eoy) %0.91.1 78.4%  
Book value per share (Unadj.) Rs757.7796.6 95.1%  
Shares outstanding (eoy) m165.9121.25 780.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.73.3 83.7%   
Avg P/E ratio x41.126.8 153.5%  
P/CF ratio (eoy) x19.225.7 74.7%  
Price / Book Value ratio x3.16.3 48.8%  
Dividend payout %35.029.1 120.3%   
Avg Mkt Cap Rs m389,034107,376 362.3%   
No. of employees `00023.53.3 708.1%   
Total wages/salary Rs m32,1493,937 816.6%   
Avg. sales/employee Rs Th6,070.89,929.3 61.1%   
Avg. wages/employee Rs Th1,366.61,185.1 115.3%   
Avg. net profit/employee Rs Th402.51,207.7 33.3%   
INCOME DATA
Net Sales Rs m142,81032,985 433.0%  
Other income Rs m1,5521,170 132.7%   
Total revenues Rs m144,36234,155 422.7%   
Gross profit Rs m23,5125,245 448.3%  
Depreciation Rs m10,772162 6,653.5%   
Interest Rs m78838 2,062.8%   
Profit before tax Rs m13,5046,215 217.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m3440-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,3802,203 198.8%   
Profit after tax Rs m9,4684,012 236.0%  
Gross profit margin %16.515.9 103.5%  
Effective tax rate %32.435.4 91.5%   
Net profit margin %6.612.2 54.5%  
BALANCE SHEET DATA
Current assets Rs m104,98422,655 463.4%   
Current liabilities Rs m68,9386,681 1,031.9%   
Net working cap to sales %25.248.4 52.1%  
Current ratio x1.53.4 44.9%  
Inventory Days Days7465 114.8%  
Debtors Days Days10429 355.3%  
Net fixed assets Rs m104,385835 12,494.2%   
Share capital Rs m830213 390.6%   
"Free" reserves Rs m124,88616,715 747.1%   
Net worth Rs m125,71616,928 742.7%   
Long term debt Rs m25,0890-   
Total assets Rs m225,44324,162 933.1%  
Interest coverage x18.1163.7 11.1%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.61.4 46.4%   
Return on assets %4.516.8 27.1%  
Return on equity %7.523.7 31.8%  
Return on capital %9.736.9 26.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m72,623369 19,705.6%   
Fx outflow Rs m18,9163,807 496.9%   
Net fx Rs m53,707-3,438 -1,562.1%   
CASH FLOW
From Operations Rs m18,0301,527 1,180.7%  
From Investments Rs m-14,883-2,148 692.7%  
From Financial Activity Rs m-4,440-1,024 433.5%  
Net Cashflow Rs m-1,236-1,646 75.1%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 5.4 7.9 68.4%  
FIIs % 35.3 0.1 35,300.0%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 17.1 89.5%  
Shareholders   75,885 18,270 415.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   PLETHICO PHARMA  BIOCON   J.B.CHEMICALS  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note; Oil & Gas and IT Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Gains were seen in the oil & gas sector and IT sector.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jun 18, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS